http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108853483-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2292 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2018-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108853483-B |
| titleOfInvention | Use of modified thymosin beta 4 for the treatment of cerebral ischemia reperfusion injury |
| abstract | The present invention relates to the field of disease treatment. In particular, the invention relates to the use of modified thymosin beta 4 for treating cerebral ischemia reperfusion injury in a subject (e.g., a human), and in the manufacture of a medicament for treating cerebral ischemia reperfusion injury in a subject (e.g., a human). The invention also relates to a method of treating cerebral ischemia reperfusion injury comprising the step of administering to a subject in need thereof the modified thymosin beta 4. |
| priorityDate | 2018-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.